Efixan Platform– Revolutionizing Animal Dermatology with Unmatched Efficacy

A Breakthrough Treatment for Hypergranulation and Insect Bite Hypersensitivity in Horses
Advancing Equine Health with Science

Our Story

Dedicated to Equine Dermatology
Passionate about Equine Skin Health

EFIXAN'S Abilities

Addressing Unmet Needs in Equine Wound Care and Dermatology

Hypergranulation (Proud Flesh)

Hypergranulation, often referred to as proud flesh, is a chronic wound complication that is characterized by abnormal vascular growth of granulation tissue does not respond to current treatments, increases veterinary costs, and requires prolonged management.

Insect Bite Hypersensitivity (IBH/Sweet Itch)

IBH, affecting up to 60% of horses in certain regions, causes intense itching and inflammation with severe damage to skin hair and coat, diminishing quality of life.

Treatment Gap

Current treatments, such as dressings and anti-inflammatory drugs, often fail to provide satisfactory solutions, leaving a critical gap in care. R-Team Biomed developed the Efixan Platform to bridge this gap, offering a novel, effective therapy, transforming outcomes for equine patients.

The New Horizons in
Animal Therapeutics

  • Large, growing market

  • Market with unmet need

  • De‐risked drug development

  • Private‐pay

  • Portfolio approach

  • Scalable and capital‐efficient

  • First mover, pure‐play

Research Insights

Insights Driving Equine Dermatology Advancements

Research and Development at the Forefront of Equine Science

Learn More

Backed by Science, Ready for Market

Global Market

Seizing a Growing Market with a Competitive Edge

$74.4B

Global Veterinary Healthcare Market by 2028
Growing at a 6.7% CAGR

$1.4B

Wound Care Segment
Growing at a 6.7% CAGR

$18.5B

Veterinary Dermatology
Growing at a 8.5% CAGR
EFIXAN's competitive advantages include advanced technology, established intellectual property, eligibility for fast-track regulatory routes, and a strong safety profile validated in both animal and human trials. This novel, peptide-based approach positions R-Team Biomed for significant market penetration in North America, Europe, and the emerging Asia Pacific region.
Learn more about global impact

Revolutionizing Biotechnology

Join Us

Discover groundbreaking innovations at R-Team, a leading biotech startup dedicated to transforming the future of healthcare. Our cutting-edge research and advanced technologies are paving the way for revolutionary treatments and diagnostics. Join us on this exciting journey as we redefine possibilities in biotechnology. Explore our projects, meet our team, and find data for potential investment.

Ready to Transform Equine Care with Efixan Techology?

Whether you're a veterinarian looking to improve patient outcomes, a horse owner seeking better care solutions, or an investor interested in a high-growth opportunity, R-Team Biomed invites you to join us on this transformative journey. Request more information about Efixan, explore partnership opportunities, or connect with our team to learn how we're redefining equine dermatology.

Veterinarians

Improve patient outcomes with breakthrough technology

Horse owner

Access better care solutions for your equine companions

Horse farms

Join a high-growth opportunity in veterinary medicine